What Researchers Did
Researchers conducted a Cochrane systematic review to evaluate the effectiveness and safety of hyperbaric oxygen therapy for individuals with autism spectrum disorder by analyzing randomized controlled trials.
What They Found
The provided abstract was truncated and did not include the main results regarding the effectiveness or adverse effects of hyperbaric oxygen therapy for autism spectrum disorder. Therefore, no specific findings or numerical data on symptom improvement or adverse events could be extracted from this summary.
What This Means for Canadian Patients
Based on the available abstract, there is no clear evidence to inform Canadian patients or clinicians about the benefits or risks of hyperbaric oxygen therapy for autism spectrum disorder. Patients should discuss all treatment options with their healthcare providers, considering the lack of conclusive data from this review.
Canadian Relevance
This systematic review does not have a direct Canadian connection.
Study Limitations
The specific limitations of the systematic review, such as the quality or number of included studies, were not available in the provided truncated abstract.